STAMFORD, Conn., Nov. 04, 2022 (GLOBE NEWSWIRE) — Sema4 (Nasdaq: SMFR), a well being insights firm, right this moment introduced it would launch monetary outcomes for the third quarter of 2022 earlier than the market opens on Monday, November 14, 2022. On the identical day, Katherine Stueland, Chief Executive Officer of Sema4, and Kevin Feeley, Chief Financial Officer of Sema4, will host a convention name to talk about monetary and working outcomes at 8:30 a.m. Eastern Time.
Conference Call Details
Sema4 will host a convention name on November 14, 2022, at 8:30 a.m. Eastern Time. Interested events might entry the reside teleconference by dialing (866) 374-5140, adopted by PIN 44463501#. A reside and archived webcast of the occasion can be obtainable on the “Events” part of the Sema4 investor relations web site at https://ir.sema4.com/.
About Sema4
Sema4 is a patient-centered well being intelligence firm devoted to advancing healthcare by means of data-driven insights. Sema4 is remodeling healthcare by making use of AI and machine studying to multidimensional, longitudinal scientific and genomic information to construct dynamic fashions of human well being and defining optimum, individualized well being trajectories. Centrellis®, our progressive well being intelligence platform, is enabling us to generate a extra full understanding of illness and wellness and to present science-driven options to essentially the most urgent medical wants. Sema4 believes that sufferers ought to be handled as companions, and that information ought to be shared for the good thing about all. For extra info, please go to sema4.com and join with us on LinkedIn, Twitter, Facebook, and Instagram.
Investor Relations Contact:
Joel Kaufman
Sema4
[email protected]
Media Contact:
Radley Moss
Sema4
[email protected]
